Rationale and design of the IRON-AF study: a double-blind, randomised, placebo-controlled study to assess the effect of intravenous ferric carboxymaltose in patients with atrial fibrillation and iron deficiency

INTRODUCTION: Atrial fibrillation (AF) is associated with significantly impaired quality-of-life. Iron deficiency (ID) is prevalent in patients with AF. Correction of ID in other patient populations with intravenous iron supplementation has been shown to be a safe, convenient and effective way of im...

Descripción completa

Detalles Bibliográficos
Autores principales: Tu, Samuel J, Elliott, Adrian D, Hanna-Rivero, Nicole, Gallagher, Celine, Mishima, Ricardo S, Lyrtzis, Ellen, Wlochowicz, Danielle, Clarke, Nicholas AR, Roberts-Thomson, Kurt C, Stokes, Michael B, Emami, Mehrdad, Lau, Dennis H, Sanders, Prashanthan, Wong, Christopher X
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8354291/
https://www.ncbi.nlm.nih.gov/pubmed/34373301
http://dx.doi.org/10.1136/bmjopen-2020-047642

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8354291/
https://www.ncbi.nlm.nih.gov/pubmed/34373301
http://dx.doi.org/10.1136/bmjopen-2020-047642

Ejemplares similares